Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Neutrophil Gelatinase Associated Lipocalin (NGAL) Levels in Hemodialysis (HD) Patients; Relation to Iron Status, Hemodialysis, and Intravenous (IV) Iron Administration

NCT00560976 is registered in ClinicalTrials.gov with Soroka University Medical Center as lead sponsor.

NCT NCT00560976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00560976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Neutrophil Gelatinase Associated Lipocalin (NGAL) Levels in Hemodialysis (HD) Patients; Relation to Iron Status, Hemodialysis, and Intravenous (IV) Iron Administration
Lead sponsor
Soroka University Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2005
Completion date
December 31, 2014
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

renal failure chronic requiring hemodialysis